These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 815173)

  • 21. mu-Chain secretion by peripheral blood lymphocytes in mu-chain disease; functional and ultrastructional characterization of cells associated with mu-chain production.
    Wetter O; Linder KH; Leene W
    Eur J Cancer (1965); 1977 Sep; 13(9):985-92. PubMed ID: 410646
    [No Abstract]   [Full Text] [Related]  

  • 22. Immunological properties of a human macroglobulin bearing antigenic determinants of mu- and gamma-chains.
    Aguilera S; Moreno C
    Vox Sang; 1976; 30(4):241-52. PubMed ID: 56086
    [No Abstract]   [Full Text] [Related]  

  • 23. The inter-chain disulfide bonds of a mu-chain disease protein.
    Mihaesco E; Mihaesco C
    FEBS Lett; 1974 Oct; 47(2):264-7. PubMed ID: 4609794
    [No Abstract]   [Full Text] [Related]  

  • 24. Biochemical and biosynthetic studies of a crystallizable human gamma 1 heavy-chain disease protein.
    Mihaesco E; Guglielmi P; Brouet JC; Mihaesco C
    Scand J Immunol; 1983 Aug; 18(2):145-52. PubMed ID: 6410498
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Immunochemical properties of free mu-chain protein in a patient with mu-heavy chain disease].
    Tamura A; Yamashiro A; Mizutani F; Oita T; Maeda A; Takahashi T
    Rinsho Byori; 2003 Sep; 51(9):847-51. PubMed ID: 14560651
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A new case of gamma heavy chain disease: clinical, immunochemical and structural characterization.
    Carbonara AO; Paolino W; Malavasi F; Levis A; Stramignoni A; de Lange G; van Loghem E; Franklin EC
    Vox Sang; 1979; 37(2):89-95. PubMed ID: 91266
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The structural heterogeneity among degraded gamma heavy chain disease proteins.
    Franklin EC
    J Immunol; 1978 Dec; 121(6):2582-3. PubMed ID: 102697
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Isolation and identification of the Cmicron4-domain of IgM.
    Bubb MO; Conradie JD
    Immunol Commun; 1977; 6(1):33-47. PubMed ID: 405314
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Study on mu chain purification and preparation of anti-mu chain serum.
    Lu ZM; Zhang DH; Wang QH; Li XM; Qin YF; Qian ZF; Huang DS
    Chin Med J (Engl); 1985 Mar; 98(3):181-6. PubMed ID: 3924510
    [No Abstract]   [Full Text] [Related]  

  • 30. Test and teach. Number One hundred and four. Mu heavy chain disease (mu-HCD).
    Campbell JK; Juneja SK
    Pathology; 2000 Aug; 32(3):202-3; 227. PubMed ID: 10968396
    [No Abstract]   [Full Text] [Related]  

  • 31. [Heavy chain disease: humoral and cellular findings in six patients with mu chain disease (author's transl)].
    Wetter O; Schmidt CG; Linder KH; Leene W
    J Cancer Res Clin Oncol; 1979 Jun; 94(2):207-23. PubMed ID: 112103
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mu-chain disease in a case of chronic lymphocytic leukaemia and malignant histiocytoma. II. Immunochemical studies.
    Axelsen NH; Harboe M; Jonsson V; Videbaek AA
    Scand J Haematol; 1976 Mar; 16(3):218-25. PubMed ID: 179131
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gamma heavy chain disease in man: synthesis of a deleted gamma3 immunoglobulin by lymphoid cells in short and long term tissue culture.
    Buxbaum JN; Alexander A; Olivier O
    Clin Exp Immunol; 1978 Jun; 32(3):489-97. PubMed ID: 80297
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Case of heavy gamma chain disease].
    Iavorkovskiĭ LI; Pushkarev IA; Guseva LN; Magalif NI; Apine RIa
    Probl Gematol Pereliv Krovi; 1978 Dec; 23(12):33-9. PubMed ID: 103089
    [No Abstract]   [Full Text] [Related]  

  • 35. Gamma heavy chain disease protein CHA: immunological and structural studies.
    Arnaud P; Wang AC; Gianazza E; Wang IY; Lasne Y; Creyssel R; Fudenberg HH
    Mol Immunol; 1981 May; 18(5):379-84. PubMed ID: 6796821
    [No Abstract]   [Full Text] [Related]  

  • 36. The interaction of immunoglobulin heavy and light chains in the absence of the VH domain.
    Levo Y; Recht B; Michaelsen T; Franklin EC; Frangione B
    J Immunol; 1977 Aug; 119(2):635-40. PubMed ID: 407302
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Low molecular weight (7S) IgM in the sera of patients with the alpha heavy chain disease (HCD) (author's transl)].
    Ayed K; Makni S; Boujnah A
    Nouv Presse Med; 1980 Jul 12-26; 9(30):2082-3. PubMed ID: 6773032
    [No Abstract]   [Full Text] [Related]  

  • 38. Some impacts of clinical investigation on immunology. Surface IgD, IgE, and heavy-chain variants.
    Franklin EC
    N Engl J Med; 1976 Mar; 294(10):531-7. PubMed ID: 814459
    [No Abstract]   [Full Text] [Related]  

  • 39. Human monoclonal cryoimmunoglobulins. I. Molecular properties of IgG3 kappa (Jir protein) and the cryo-coprecipitability of its molecular fragments by papain.
    Nishimura Y; Nakamura H
    J Biochem; 1984 Jan; 95(1):255-65. PubMed ID: 6423624
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Two-dimensional gel electrophoresis as an aid in the analysis of monoclonal gammopathies.
    Tracy RP; Kyle RA; Young DS
    Hum Pathol; 1984 Feb; 15(2):122-9. PubMed ID: 6421714
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.